Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Diabet Med ; 35(10): 1404-1411, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-29939421

RESUMEN

AIMS: To determine the duration of the low hypoglycaemia risk period after the start of moderate-intensity exercise performed under basal insulinaemic conditions and whether this period is affected by the level at which glycaemia is maintained under these conditions. METHODS: This was a prospective, randomized counterbalanced study. Eight participants with Type 1 diabetes (mean ± sd age 21.5 ± 4.0 years) underwent either a euglycaemic (5-6 mmol/l) or hyperglycaemic clamp (9-10 mmol/l) on separate days and were infused with insulin at basal rates and [6,6-2 H]glucose while cycling for 40 min at 50% maximum oxygen consumption rate. The main outcome measures were the glucose infusion rates required to maintain stable glycaemia and glucoregulatory hormone levels, and rates of glucose appearance and disappearance. RESULTS: During the first 20 min of exercise, the glucose infusion rate did not increase significantly, irrespective of the level at which glycaemia was maintained, but increased acutely between 20 and 25 min under both conditions. Maintaining higher glycaemia resulted in higher glucose infusion rate during, but not early post-exercise. With the exception of epinephrine, the glucoregulatory hormone levels and rates of glucose appearance and disappearance were similar between conditions. CONCLUSION: Irrespective of the levels at which glycaemia is maintained, there is a 20-min low exogenous glucose demand period during which the exogenous glucose requirements to maintain stable glycaemia do not increase during moderate exercise performed at basal insulin level.


Asunto(s)
Glucemia/metabolismo , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Ejercicio Físico/fisiología , Glucosa/administración & dosificación , Hiperinsulinismo/tratamiento farmacológico , Hipoglucemia/tratamiento farmacológico , Insulina/efectos adversos , Adolescente , Adulto , Glucemia/efectos de los fármacos , Diabetes Mellitus Tipo 1/sangre , Diabetes Mellitus Tipo 1/complicaciones , Esquema de Medicación , Ayuno/sangre , Femenino , Humanos , Hiperinsulinismo/sangre , Hiperinsulinismo/inducido químicamente , Hipoglucemia/inducido químicamente , Insulina/administración & dosificación , Masculino , Factores de Tiempo , Adulto Joven
2.
Diabet Med ; 34(10): 1440-1446, 2017 10.
Artículo en Inglés | MEDLINE | ID: mdl-28586510

RESUMEN

AIM: To investigate whether a 10-second (s) sprint impairs the counter-regulatory response to subsequent hypoglycaemia. METHODS: Nine people (five male, four female) with Type 1 diabetes, aged 21.1 ± 4.5 years, performed a 10-s rest or a 10-s maximum-effort sprint in random order on different days, while subjected to an euinsulinaemic-euglycaemic clamp. This was followed by a hyperinsulinaemic-hypoglycaemic glucose clamp 2.5 h later to induce hypoglycaemia for 40 min. At timed intervals, the counter-regulatory hormonal responses to hypoglycaemia were measured. Blood pressure, heart rate and hypoglycaemic symptoms were also assessed. RESULTS: During the hypoglycaemic clamp, epinephrine, norepinephrine, growth hormone and cortisol levels increased significantly from baseline, and their responses were similar after both rest and sprint conditions. In particular, plasma epinephrine rose eightfold, from 197 ± 103 pmol/l to 1582 ± 1118 pmol/l after the rest condition, and from 219 ± 119 pmol/l to 1900 ± 898 pmol/l after the sprint condition. CONCLUSION: A 10-s sprint is unlikely to blunt the subsequent hormonal counter-regulation to hypoglycaemia in individuals with Type 1 diabetes.


Asunto(s)
Glucemia/metabolismo , Diabetes Mellitus Tipo 1/sangre , Epinefrina/sangre , Glucagón/sangre , Hipoglucemia/sangre , Carrera/fisiología , Adolescente , Adulto , Diabetes Mellitus Tipo 1/complicaciones , Femenino , Técnica de Clampeo de la Glucosa , Humanos , Hipoglucemia/etiología , Hipoglucemia/metabolismo , Insulina/sangre , Masculino , Norepinefrina/sangre , Adulto Joven
3.
Arch Dis Child ; 85(4): 335-6, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11567946

RESUMEN

An 11 month old boy presented with gangrene of the extremities. He was found to have positive nuclear antibodies and antibodies to double stranded DNA, and negative Ro and La antibodies. The infant was started on oral prednisolone, which was discontinued after six months. At one year of follow up he was asymptomatic, with negative nuclear antibodies and antibodies to double stranded DNA.


Asunto(s)
Dedos/patología , Lupus Eritematoso Sistémico/complicaciones , Dedos del Pie/patología , Gangrena/etiología , Glucocorticoides/uso terapéutico , Humanos , Lactante , Lupus Eritematoso Sistémico/diagnóstico , Lupus Eritematoso Sistémico/tratamiento farmacológico , Masculino , Prednisolona/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...